Genome International Biomedical Co. Ltd filed its Annual on Mar 27, 2015 for the period ending Dec 31, 2014. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.1 TWD | 0.00% | +3.21% | -29.94% |
1st Jan change | Capi. | |
---|---|---|
-29.94% | 33.01M | |
+23.92% | 74.5B | |
-2.46% | 24.24B | |
+10.52% | 8.45B | |
+4.65% | 8.44B | |
-21.71% | 7.65B | |
+11.90% | 5.24B | |
+2.27% | 4.14B | |
-4.23% | 3.95B | |
+5.42% | 3.83B |
- Stock Market
- Equities
- 6130 Stock
- News Shangya Technology Co., Ltd.
- Genome International Biomedical Co. Ltd Auditor Raises 'Going Concern' Doubt